These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16188717)

  • 21. Methamphetamine and HIV.
    HRSA Careaction; 2009 Jun; ():1-8. PubMed ID: 19731419
    [No Abstract]   [Full Text] [Related]  

  • 22. Behavioral health issue brief: treatment of methamphetamine abuse: year end report-2002.
    Colker AC
    Issue Brief Health Policy Track Serv; 2002 Dec; ():1-8. PubMed ID: 12875274
    [No Abstract]   [Full Text] [Related]  

  • 23. [Stimulant dependence].
    Kishimoto H
    Ryoikibetsu Shokogun Shirizu; 2003; (40):505-6. PubMed ID: 14626171
    [No Abstract]   [Full Text] [Related]  

  • 24. Methamphetamine users show greater than normal age-related cortical gray matter loss.
    Nakama H; Chang L; Fein G; Shimotsu R; Jiang CS; Ernst T
    Addiction; 2011 Aug; 106(8):1474-83. PubMed ID: 21438934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methamphetamine and meth mouth: an overview.
    Williams N; Covington JS
    J Tenn Dent Assoc; 2006; 86(4):32-5. PubMed ID: 17228534
    [No Abstract]   [Full Text] [Related]  

  • 26. Methamphetamine abuse: a review of the literature and case report in a young male.
    Naidoo S; Smit D
    SADJ; 2011 Apr; 66(3):124-7. PubMed ID: 21874893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. METHAMPHETAMINE: WHERE WILL THE STAMPEDE TAKE US?
    Sullivan D; McDonough Michael
    J Law Med; 2015 Sep; 23(1):41-9. PubMed ID: 26554196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Explanations for methamphetamine use among gay and bisexual men in New York City.
    Halkitis PN; Fischgrund BN; Parsons JT
    Subst Use Misuse; 2005; 40(9-10):1331-45. PubMed ID: 16048820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychological Burden and Gender Differences in Methamphetamine-Dependent Individuals in Treatment.
    Simpson JL; Grant KM; Daly PM; Kelley SG; Carlo G; Bevins RA
    J Psychoactive Drugs; 2016; 48(4):261-9. PubMed ID: 27541988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive Deficits in Methamphetamine Users: How Strong is The Evidence?
    Proebstl L; Kamp F; Koller G; Soyka M
    Pharmacopsychiatry; 2018 Nov; 51(6):243-250. PubMed ID: 29334687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methamphetamine abuse and dentistry.
    Hamamoto DT; Rhodus NL
    Oral Dis; 2009 Jan; 15(1):27-37. PubMed ID: 18992021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
    Kinner SA; Degenhardt L
    Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meth mouth: a national scourge.
    Mallatt ME
    J Indiana Dent Assoc; 2005; 84(3):28-9. PubMed ID: 16359093
    [No Abstract]   [Full Text] [Related]  

  • 34. Impulsivity and methamphetamine use.
    Semple SJ; Zians J; Grant I; Patterson TL
    J Subst Abuse Treat; 2005 Sep; 29(2):85-93. PubMed ID: 16135337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High concentrations of plasma brain-derived neurotrophic factor in methamphetamine users.
    Kim DJ; Roh S; Kim Y; Yoon SJ; Lee HK; Han CS; Kim YK
    Neurosci Lett; 2005 Nov; 388(2):112-5. PubMed ID: 16039058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A qualitative exploration of perceived gender differences in methamphetamine use among women who use methamphetamine on the Mexico-U.S. border.
    Loza O; Ramos R; Ferreira-Pinto J; Hernandez MT; Villalobos SA
    J Ethn Subst Abuse; 2016; 15(4):405-424. PubMed ID: 26689233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meth use linked to risk of Parkinson disease.
    Kuehn BM
    JAMA; 2011 Aug; 306(8):814. PubMed ID: 21862738
    [No Abstract]   [Full Text] [Related]  

  • 38. Methamphetamine use in Dayton, Ohio: preliminary findings from the Ohio Substance Abuse Monitoring Network.
    Daniulaityte R; Carlson RG; Kenne DR
    J Psychoactive Drugs; 2007 Sep; 39(3):211-21. PubMed ID: 18159774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methods in drug abuse models: comparison of different models of methamphetamine paradigms.
    Kobeissy FH; Mitzelfelt JD; Fishman I; Morgan D; Gaskins R; Zhang Z; Gold MS; Wang KK
    Methods Mol Biol; 2012; 829():269-78. PubMed ID: 22231820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of methamphetamine neurotoxicity in forensic autopsy cases.
    Kitamura O
    Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S63-5. PubMed ID: 19269222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.